ERBB2 and breast cancer: Among different types of breast cancer, triple negative breast cancer (TNBC; ER, PR, and HER2-negative breast cancer), accounting for approximately 10–20% of breast cancer cases, is one of the most difficult subtypes of breast cancer to treat due to its aggressive, metastatic behavior, and a lack of a targeted therapy [1].